CYTOF — Altamira Therapeutics Ltd.

—
OTC · Health Care · Pharmaceuticals · CIK 1601936 ·
Last close
$0.07
Market Cap
$405.8K
52W High
$0.15
52W Low
$0.05
ADV30
4,153
Next earnings
2026-11-24

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2025 — — — — 7,130,183 3,755 3,056,371

Balance + Analyst (yfinance extras)

Retained Earnings
$-4,041,241
Inventory
—
Receivables
$213,389
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2024 0 -6,921,740 -8,457,748 8,652,136 2,087,030 6,565,106 -6,113,547
Dec 2023 0 -6,601,112 -4,306,260 9,143,504 1,468,261 7,675,243 -12,811,427
Dec 2022 0 -18,862,743 -27,778,443 6,810,000 15,800,000 -8,988,013 -9,092,388
Dec 2021 0 -7,517,066 -18,661,463 20,971,798 6,710,502 14,261,296 -14,957,595

Peers — same industry

TickerNameMarket CapLastDaily %
VBIO Valion Bio, Inc. $482.3K $0.54 —
LABT Lakewood-Amedex Biotherapeutics Inc. $508.3K $0.21 —
EVFM Evofem Biosciences, Inc. $569.9K $0.00 —
BIOM BIOMOLECULAR LIFE HOLDINGS, INC. $580.8K $0.50 —
PTIX Protagenic Therapeutics, Inc.\new $814.6K $0.45 —

News headlines (Yahoo Finance, 1h cache)

Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis
2026-04-13 13:00 · Yahoo
Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
2026-03-31 13:00 · Yahoo
Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements
2026-03-24 13:00 · Yahoo
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray
2026-02-13 14:00 · Yahoo
Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China
2025-12-19 14:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.